Medicare Enrolled
Dr. Valerie Galante, CRNP
Nurse Practitioner - Adult Health · Wyomissing, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Galante from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Galante?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Galante
Dr. Valerie Galante is a nurse practitioner - adult health in Wyomissing, PA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Galante performed 38,424 Medicare services across 2,178 unique beneficiaries.
Between the years covered by Open Payments, Dr. Galante received a total of $8,376 from 38 pharmaceutical and/or device companies across 416 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - adult health. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Galante is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 0% volume in PA
$8,376 industry payments
Medicare Practice Summary
Medicare Utilization ↗38,424
Medicare services
Top 0% in PA for nurse practitioner - adult health
2,178
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,269 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 21,360 | $18 | $30 |
| Romosozumab injection (Evenity) for osteoporosis | 13,650 | $8 | $12 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
931 | $1 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
322 | $74 | $195 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
266 | $31 | $225 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
260 | $9 | $80 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
235 | $6 | $70 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
228 | $35 | $145 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
226 | $52 | $130 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
166 | $78 | $262 |
| New patient office visit, complex (60-74 min) | 107 | $131 | $384 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
105 | $31 | $80 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
75 | $38 | $150 |
| Ultrasound-guided small joint aspiration or injection This procedure involves removing fluid from or injecting medication into a small joint while using ultrasound imaging to guide the needle placement. |
73 | $55 | $208 |
| Viscosupplementation injection for joint An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning. |
62 | $57 | $180 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
60 | $41 | $152 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
57 | $42 | $300 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
44 | $82 | $325 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
41 | $31 | $150 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
40 | $35 | $84 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
36 | $24 | $194 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
29 | $24 | $41 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $109 | $265 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
16 | $21 | $44 |
| Ultrasound-guided joint aspiration or injection Removal of fluid from or injection into a medium-sized joint using ultrasound guidance to ensure accurate placement. |
15 | $64 | $192 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
96.7% medium
3.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,376
Total received (2021-2024)
Avg $2,094/year across 4 years
Top 5% in PA for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
416
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,376 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,819
2023
$2,388
2022
$1,617
2021
$1,551
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$544
UCB, Inc.
$539
Amgen Inc.
$467
Janssen Biotech, Inc.
$233
AstraZeneca Pharmaceuticals LP
$175
ANI Pharmaceuticals, Inc.
$105
GlaxoSmithKline, LLC.
$104
Novartis Pharmaceuticals Corporation
$80
Genentech USA, Inc.
$67
Kyowa Kirin, Inc.
$59
Radius Health, Inc.
$53
E.R. Squibb & Sons, L.L.C.
$52
Almatica Pharma LLC
$49
GENZYME CORPORATION
$47
PFIZER INC.
$45
DePuy Synthes Sales Inc.
$34
Kiniksa Pharmaceuticals International, plc
$29
Daiichi Sankyo Inc.
$29
SOBI, INC
$28
Aurinia Pharma U.S., Inc.
$25
Lilly USA, LLC
$19
TerSera Therapeutics LLC
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Top 3 companies account for 55.0% of 2024 payments
All-time payments by company (2021-2024) ›
Amgen Inc.
$1,615
ABBVIE INC.
$1,474
UCB, Inc.
$912
Janssen Biotech, Inc.
$506
AstraZeneca Pharmaceuticals LP
$413
AbbVie Inc.
$368
GlaxoSmithKline, LLC.
$344
Radius Health, Inc.
$254
ANI Pharmaceuticals, Inc.
$211
Aurinia Pharma U.S., Inc.
$207
PFIZER INC.
$204
Lilly USA, LLC
$204
E.R. Squibb & Sons, L.L.C.
$189
Novartis Pharmaceuticals Corporation
$169
Mallinckrodt Hospital Products Inc.
$158
Alexion Pharmaceuticals, Inc.
$102
DePuy Synthes Sales Inc.
$100
GENZYME CORPORATION
$89
Kyowa Kirin, Inc.
$87
Genentech USA, Inc.
$78
Organon LLC
$77
Ultragenyx Pharmaceutical Inc.
$70
Exeltis, USA Inc.
$59
SOBI, INC
$56
Actelion Pharmaceuticals US, Inc.
$52
Almatica Pharma LLC
$49
Sobi, Inc
$45
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
Kiniksa Pharmaceuticals, Ltd.
$31
Bioventus LLC
$29
Kiniksa Pharmaceuticals International, plc
$29
Daiichi Sankyo Inc.
$29
Horizon Therapeutics plc
$28
Fresenius Kabi USA, LLC
$28
TerSera Therapeutics LLC
$18
Sandoz Inc.
$18
Orthogenrx Inc.
$17
Teva Pharmaceuticals USA, Inc.
$16
Top 3 companies account for 47.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Arcalyst · BENLYSTA · Bimzelx · Briviact · COSENTYX · CYLTEZO · Cimzia · Crysvita · EVENITY · Enbrel · Fintepla · GELSYN-3 · HUMIRA · HYRIMOZ · IDACIO · INFLECTRA · INJECTAFER · KEVZARA · KINERET · KRYSTEXXA · Kineret · LOREEV XR · LUPKYNIS · MONOVISC · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · PURIFIED CORTROPHIN GEL · Quzyttir · RENFLEXIS · RINVOQ · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPEVIGO · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TREMFYA · TriVisc sodium hyaluronate · Truxima · Tymlos · ULTOMIRIS · Ultomiris · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for nurse practitioner - adult health in PA.
Geographic Context
Adult-health nurse practitioners within 10 mi
50
Per 100K population
11.6
County median income
$77,684
Nearest hospital
SURGICAL INSTITUTE OF READING
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Galante is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with low-engagement industry engagement in the top 5% of PA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Galante experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Galante performed 21,360 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Galante receive payments from pharmaceutical companies?
Yes. Dr. Galante received a total of $8,376 from 38 companies across 416 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Galante's costs compare to other adult-health nurse practitioners in Wyomissing?
Dr. Galante's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Galante) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Adult-Health Nurse Practitioners in Wyomissing
Browse adult-health nurse practitioners in Wyomissing ranked by procedure volume and transparency data.
Highest volume
Top Adult-Health Nurse Practitioners in PA
Adult-health nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Adult-Health Nurse Practitioners in PA
Which PA adult-health nurse practitioners receive the most from drug and device companies.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology